All In Biotech

Drug Trial Radar · NCT05186818

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM

A Phase 3, Multi-Center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of CK-3773274 in Adults With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction

Last checked: Nov 20, 2026Latest source record: Mar 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 282 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

282

Actual

Start

Feb 1, 2022

Primary completion

Nov 10, 2023

Study completion Dec 18, 2023

Sponsor

Lead sponsor
CytokineticsIndustry
Sponsor type
Industry
Collaborators
Corxel Pharmaceuticals
First posted
Jan 11, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of aficamten (CK-3773274) versus placebo in adults with symptomatic hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract obstruction.

Conditions

  • Obstructive Hypertrophic Cardiomyopathy (oHCM)

Interventions

  • Aficamten (5 mg, 10 mg, 15 mg, and 20 mg)Drug

    Aficamten tablets were administered orally once daily.

  • Placebo to match aficamtenDrug

    Placebo tablets were administered orally once daily.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in pVO2 at Week 24Time frame: Baseline to Week 24

Locations

114 sites in 14 countries. Site status is shown where the registry gives one.

  • Alaska Heart and Vascular Institute

    Anchorage, Alaska

  • UC San Diego Health - Sulpizio Cardiovascular Center

    La Jolla, California

  • Cedars-Sinai Medical Center - Smidt Heart Institute Clinic

    Los Angeles, California

  • University of California San Francisco

    San Francisco, California

  • Stanford University Hospital

    Stanford, California

  • Yale School of Medicine

    New Haven, Connecticut

  • Yale University School of Medicine

    New Haven, Connecticut

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia

  • Holy Cross Hospital / Cardiology Associates

    Fort Lauderdale, Florida

  • Mayo Clinic Florida

    Jacksonville, Florida

  • Emory Clinic

    Atlanta, Georgia

  • Piedmont Fayette Hospital

    Fayetteville, Georgia

  • Northwestern University

    Chicago, Illinois

  • University of Iowa

    Iowa City, Iowa

  • MedStar Medical Group Cardiology at Union Memorial

    Baltimore, Maryland

  • Medstar Franklin Square Medical Center

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Brigham and Women's Hospital

    Boston, Massachusetts

  • Lahey Hospital & Medical Center

    Burlington, Massachusetts

  • Michigan Medicine

    Ann Arbor, Michigan

  • Henry Ford Medical Center

    Detroit, Michigan

  • Spectrum Health Medical Group Cardiovascular Medicine

    Grand Rapids, Michigan

  • M Health Fairview University of Minnesota Medical Center - East Bank

    Minneapolis, Minnesota

  • Mayo Clinic

    Rochester, Minnesota

  • Saint Luke's Hospital of Kansas City

    Kansas City, Missouri

  • Washington University School of Medicine

    St Louis, Missouri

  • Morristown Medical Center

    Morristown, New Jersey

  • NYU Langone Health

    New York, New York

  • Mount Sinai Hospital

    New York, New York

  • Columbia University Medical Center/NY Presbyterian Hospital

    New York, New York

  • Westchester Medical Center

    Valhalla, New York

  • Sanger Heart and Vascular Institute

    Charlotte, North Carolina

  • Sanger Heart and Vascular Institute - HCM Clinic

    Charlotte, North Carolina

  • Duke Health Center Arringdon

    Morrisville, North Carolina

  • Cleveland Clinic

    Cleveland, Ohio

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio

  • Ascension St. John Clinical Research Institute

    Tulsa, Oklahoma

  • Oregon Health & Science University

    Portland, Oregon

  • Hospital of the University of Pennsylvania (University of Pennsylvania School of Medicine)

    Philadelphia, Pennsylvania

  • UPMC Presbyterian

    Pittsburgh, Pennsylvania

Showing 40 of 114 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.